Abstract Library

#2952 Genomic Landscape of Neuroendocrine Neoplasms from Gastrointestinal Tract, Pancreas, Lung, Rare and Unknown Primary Locations

Introduction: There are still few large-scale sequencing data to depict the genomic landscape of neuroendocrine neoplasms (NEN).

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Chen L

Authors: Chen L, Liu M, Zhang Y, Guo Y, Chen M,

Keywords: Genomics, neuroendocrine neoplasm, survival,

#2108 Molecular Characterization of Primary and Metastatic Pancreatic Neuroendocrine Tumors

Introduction: Pancreatic neuroendocrine tumours (PNETs) are a heterogeneous group of rare pancreatic neoplasms often diagnosed with distant metastases, which are associated with significantly poorer prognosis. Recurrent somatic mutations, chromosomal aberrations and gene expression signatures in PNETs have been described, but the clinical significance of these molecular changes is still poorly understood, and the clinical outcomes of PNET patients remain highly variable.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Yang K, Wong H, Shen Y, Colborne S, Kalloger S,

Keywords: pancreatic neuroendocrine tumor, metastasis, primary tumor, proteomics, transcriptomics,

#2012 Expression and Clinical Significance of Vascular Endothelial Growth Factor D in Gastroenteropancreatic Neuroendocrine Neoplasms

Introduction: The expression of vascular endothelial growth factor D (VEGF-D) in tumor cells versus stroma cells in gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) and its clinical significance is still unknown.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Zhang Y

Authors: Zhang Y, Chen L, Lin Y, Chen M, Chen J,

Keywords: gastroenteropancreatic neuroendocrine neoplasms, vascular endothelial growth factor D, expression, clinical significance,

#2011 Expression and Clinical Significance of Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) and Phospho-VEGFR3 in Gastroenteropancreatic Neuroendocrine Neoplasms

Introduction: The expression of vascular endothelial growth factor Receptor 3 (VEGFR3) and phospho-VEGFR3 (pVEGFR3) in gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) and their clinical significance are still unknown.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Zhang Y

Authors: Zhang Y, Chen L, Lin Y, Chen M, Chen J,

Keywords: gastroenteropancreatic neuroendocrine neoplasms, vascular endothelial growth factor Receptor 3, expression, clinical significance,

#1690 18F-FDG-PET to Discriminate Biologically Malignant Pancreatic Neuroendocrine Tumors

Introduction: 18F-FDG-PET is widely used to detect malignant tumors. However, the efficacy for pancreatic neuroendocrine tumors (PNETs) is reported to be limited in the clinical practice.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Sato A, Toshihiko M, Kenzo N, Yuichiro U, Yuji N,

Keywords: 18F-FDG-PET, pancreatic neuroendocrine tumors (p-nets), metastasis,